drug

Ebola Zaire vaccine

Marketedupdated 3mo ago

by $MRK Merck & Co., Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Ebola Zaire vaccine

phase4REVIVE (Response to the Ebola Virus Vaccine)active not recruitingn=40
phase2Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteersnot yet recruitingn=132

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

Ebola Zaire vaccine

Marketedupdated 3mo ago

by $MRK Merck & Co., Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying Ebola Zaire vaccine

phase4REVIVE (Response to the Ebola Virus Vaccine)active not recruitingn=40
phase2Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteersnot yet recruitingn=132

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 1h ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

Ebola Zaire vaccine

all catalysts(0)

Trials studying Ebola Zaire vaccine

News(0)

Report a data issue

comments(0)

Ebola Zaire vaccine

all catalysts(0)

Trials studying Ebola Zaire vaccine

News(0)

Report a data issue

comments(0)